Skip to main content

Table 2 Demographics of study subjects.

From: CLC-2 single nucleotide polymorphisms (SNPs) as potential modifiers of cystic fibrosis disease severity

 

FEV1

Gender

Age (years) (± SEM)

Severe

35.6 (3.13)

9 M / 6 F

24.7 (1.56)

Mild

77.4 (3.18)

9 M / 7 F

22.6 (1.37)